SOLOIST-WHF
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effects of SOtagLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POST Worsening Heart Failure
- Stage
- klaar
- Medicine
- sotagliflozin
- Population
- Hartfalen
- Phase
- III
- First Patient In
- 15 October 2018
- Last Patient In
- 1 May 2020
- Last Patient Last Visit
- 19 May 2020
National Lead
